Inventor

Ahmed Merzouk

Inventor

Richmond, CA

Overview

2004–2018

Patent span

Human necessities

Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes29%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%

A01KAnimal husbandry20%

Y02ATechnologies for adaptation to climate change20%

C07KPeptides5%

A01NPreservation of bodies of humans or animals or plants or parts thereof1%

C12NMicroorganisms or enzymes1%

PatentTitleYear

10,064,897Treating a bacterial skin infection with a whole, leech saliva extract2018 9,597,361'Treating a bacterial skin infection with a whole, leech saliva extract'2017 9,480,720'Treating damaged dermal or mucosal tissue with a whole, leech saliva extract'2016 9,433,649'Treating a lymphoma with a whole, leech saliva extract'2016 9,433,648'Treating renal cancer with a whole, leech saliva extract'2016 9,265,803'Treating a melanoma with a whole, leech saliva extract'2016 9,265,802'Treating colorectal cancer with a whole, leech saliva extract'2016 9,149,498'Treating a parasitic disease with a whole, leech saliva extract'2015 9,144,587'Treating pancreatic carcinoma with a whole, leech saliva extract'2015 9,017,732'Antibacterial therapy with a whole, leech saliva extract'2015 9,005,667'Treating leukemia with a whole, leech saliva extract'2015 8,962,034'Antiviral therapy with a whole, leech saliva extract'2015 8,932,642'Treating prostate, ovarian, or breast cancer with a whole, leech saliva extract'2015 8,790,711'Treating diabetes with a whole, leech saliva extract'2014 8,784,896'Antioxidant therapy with a whole, leech saliva extract'2014 8,685,462'Whole, leech saliva product and applications thereof'2014 8,501,241'Treating cancer with a whole, leech saliva extract'2013 7,994,114'Chemokine mimetics synthesis and their use'2011 7,939,498'Cyclic peptides for preserving or enhancing the function of an organ allograft'2011 7,435,718'CXCR4 antagonist treatment of hematopoietic cells'2008 7,378,098'CXC chemokine receptor 4 agonist peptides'2008 7,368,425'Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis'2008 7,091,310'Chemokine analogs for the treatment of human disease'2006 6,831,101'Tricyclic rantes receptor ligands'2004 6,693,134'Bicyclic aromatic chemokine receptor ligands'2004

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2004–2008Patents assigned to CHEMOKINE THERAPEUTICS CORP (6)· patent assignee history

2004–2018Based in Richmond, CA· patent location history

2008Patents assigned to UNIV BRITISH COLUMBIA (2)· patent assignee history

2011Patents assigned to BRITISH CANADIAN BIOSCIENCES CORP (2)· patent assignee history

2013–2018Patents assigned to BIOPEP SOLUTIONS INC (17)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BIOPEP SOLUTIONS INC	17	2013–2018
CHEMOKINE THERAPEUTICS CORP	6	2004–2008
BRITISH CANADIAN BIOSCIENCES CORP	2	2011
UNIV BRITISH COLUMBIA	2	2008

Locations

Location	Patents	Span
Richmond, CA	25	2004–2018